Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04391686
Other study ID # 2020-04
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 3, 2020
Est. completion date November 4, 2021

Study information

Verified date March 2022
Source Centre Hospitalier Arras
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Compare the resting energy expenditure of COVID-19 patients (obese or non-obese) in intensive care unit with mechanical ventilation to a control group of non-COVID-19 intensive care patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date November 4, 2021
Est. primary completion date November 4, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: For the Ambulatory Obese Control Group, the inclusion criteria are: - Age = 18 years; - Patient followed in the nutrition service; - Patient who benefited from an indirect calorimetry whatever the indication between 01/01/20 and 31/12/2020; - BMI> 30. For the COVID Group and the Resuscitation Control Group, the inclusion criteria are: - Age = 18 years; - Patient having undergone a resuscitation stay - Patient on mechanical ventilation (intubated or tracheotomized) during their stay in intensive care; - Patient having benefited from an indirect calorimetry upon arrival in intensive care; Only for the COVID Group: - Patient hospitalized in intensive care for COVID 19 infection diagnosed by a positive PCR via nasopharyngeal sampling or endotracheal aspiration. - Patient who has not yet carried out his post-resuscitation visit; Only for the Resuscitation Control Group: - Patient hospitalized in intensive care for an indication other than an infectious cause. Exclusion Criteria: Non-inclusion criteria for the Ambulatory Obese Control Group: - Person deprived of liberty; - Person subject to legal protection measures; - Patient's opposition to participate in research. The non-inclusion criteria for the COVID Group and the Resuscitation Control Group: - For patients intubated during the resuscitation stay Fi02> 70% which does not allow a correct interpretation of the calorimetry; - Pregnancy ; - Person deprived of liberty; - Person subject to legal protection measures; - Opposition of the patient or the person of trust to participate in the research. Only for the COVID Group: - Contraindication to indirect calorimetry (claustrophobia for post-resuscitation patients where calorimetry is performed with a mask); - Contraindication to bioimpedancemetry (electronic implants, limb amputation, weight <30kg or> 300kg);

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
indirect calorimetry
to determine and compare the resting energy expenditure of each group

Locations

Country Name City State
France Arras general hospital Arras

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Arras

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The resting energy expenditure (in Kcal / 24h) measured by indirect calorimetry during the stay in intensive care. baseline and 3 months later
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2